Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.

Carvalho S, Catarino TA, Dias AM, Kato M, Almeida A, Hessling B, Figueiredo J, Gärtner F, Sanches JM, Ruppert T, Miyoshi E, Pierce M, Carneiro F, Kolarich D, Seruca R, Yamaguchi Y, Taniguchi N, Reis CA, Pinho SS

Open source

DOI: 10.1038/onc.2015.225
Published: 2016 Mar 31
Container: Oncogene
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/onc.2015.225,
  title = {Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.},
  author = {Carvalho S and Catarino TA and Dias AM and Kato M and Almeida A and Hessling B and Figueiredo J and Gärtner F and Sanches JM and Ruppert T and Miyoshi E and Pierce M and Carneiro F and Kolarich D and Seruca R and Yamaguchi Y and Taniguchi N and Reis CA and Pinho SS},
  year = {2016},
  journal = {Oncogene},
  doi = {10.1038/onc.2015.225},
  url = {https://doi.org/10.1038/onc.2015.225}
}

RIS

TY  - JOUR
TI  - Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.
AU  - Carvalho S
AU  - Catarino TA
AU  - Dias AM
AU  - Kato M
AU  - Almeida A
AU  - Hessling B
AU  - Figueiredo J
AU  - Gärtner F
AU  - Sanches JM
AU  - Ruppert T
AU  - Miyoshi E
AU  - Pierce M
AU  - Carneiro F
AU  - Kolarich D
AU  - Seruca R
AU  - Yamaguchi Y
AU  - Taniguchi N
AU  - Reis CA
AU  - Pinho SS
PY  - 2016
JO  - Oncogene
DO  - 10.1038/onc.2015.225
UR  - https://doi.org/10.1038/onc.2015.225
ER  -

APA

S, C., TA, C., AM, D., M, K., A, A., B, H., J, F., F, G., JM, S., T, R., E, M., M, P., F, C., D, K., R, S., Y, Y., N, T., CA, R., & SS, P. (2016). Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.. Oncogene. https://doi.org/10.1038/onc.2015.225

Source records

pubmed · retrieved 2026-09-25T09:21:06.632Z
europe-pmc · retrieved 2026-09-25T09:21:06.616Z